Replay to "duration more than type of dual antiplatelet therapy matters in ACS patients with high bleeding risk". Fujii T. Int J Cardiol 2023;381:1.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fujii T. Replay to "duration more than type of dual antiplatelet therapy matters in ACS patients with high bleeding risk". Int J Cardiol 2023;381:1.
PMID: 36933664